Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 19 | 0 | 3 | 0 | €199.20 | €207.72 | 4.275% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €201.00 | €204.50 | 1.741% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €154.22 | €200.06 | 29.722% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €148.70 | €182.96 | 23.040% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €150.90 | €174.43 | 15.595% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €142.50 | €165.00 | 15.789% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €154.00 | €159.70 | 3.704% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €133.00 | €150.00 | 12.782% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €126.15 | €147.62 | 17.016% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.35 | €144.44 | 12.540% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €134.30 | €137.63 | 2.483% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €119.10 | €136.82 | 14.880% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €129.14 | €133.66 | 3.501% |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €120.00 | €130.44 | 8.698% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €128.25 | €130.00 | 1.365% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €121.20 | €124.93 | 3.077% |
| Davita Inc. | 2 | 0 | 0 | 0 | €131.05 | €124.89 | -4.702% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €91.00 | €124.85 | 37.195% |
| iRhythm Technologies Inc | 10 | 0 | 0 | 0 | €100.00 | €122.84 | 22.839% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €99.63 | €116.81 | 17.241% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €103.10 | €110.00 | 6.693% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €62.50 | €109.59 | 75.336% |